← FDA DRUG APPROVALS

FDA ANDA · ANDA090610

CHLOROQUINE PHOSPHATE

Sponsor: IPCA LABS LTD

APPLICATION
ANDA090610
TYPE
ANDA
ORIGINAL APPROVAL
2009-12-03
LATEST ACTION
2023-07-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CHLOROQUINE PHOSPHATEDiscontinued
CHLOROQUINE PHOSPHATE 250MG · TABLET · ORAL

Approval history

2023-07-24Labeling · Supplement 10 · standardAP
2022-05-03Labeling · Supplement 9 · standardAP
2022-03-17Labeling · Supplement 8 · standardAP
2020-03-26Labeling · Supplement 5 · standard — Label ↗AP
2020-03-26Labeling · Supplement 4 · standard — Label ↗AP
2016-02-12Labeling · Supplement 3 · standardAP
2009-12-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →